{"transactions":[{"id":4623140,"issuer":{"id":6324,"kind":"organization","name":"NovaBridge Biosciences","symbol":"NBP"},"owners":[{"id":36207,"kind":"person","name":"Dennis Phillip Andrew","position":1,"cik":"0002089237","reported_name":"Dennis Phillip Andrew","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Restricted Share Units","published_at":"2026-09-21T20:05:06.000Z","date":"2026-09-17","kind":"exercise","planned":false,"acquired":false,"shares":10302,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one ADS."},{"field":"shares","element":"transactionShares","label":"F8","text":"Reported securities represent ADSs."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F9","text":"On June 17, 2024, the Reporting Person was granted 164,840 RSUs. The RSUs vested or shall vest over four years, with one-fourth vesting on the first anniversary of the grant date and the balance vesting ratably over the subsequent 12 quarters on the 17th day of each third month."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F9","text":"On June 17, 2024, the Reporting Person was granted 164,840 RSUs. The RSUs vested or shall vest over four years, with one-fourth vesting on the first anniversary of the grant date and the balance vesting ratably over the subsequent 12 quarters on the 17th day of each third month."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares (\"ADS\"). Each 10 ADSs represent 23 Ordinary Shares of the Issuer."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F8","text":"Reported securities represent ADSs."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F8","text":"Reported securities represent ADSs."}],"balance_after":72120,"derivative":{"underlying":"Ordinary Shares","underlying_shares":10302},"source":{"system":"sec-edgar","filing":"0002089237-26-000008","document":"form4-09212026_040901.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/2089237/000208923726000008/form4-09212026_040901.xml","form_type":"4"}},{"id":4623139,"issuer":{"id":6324,"kind":"organization","name":"NovaBridge Biosciences","symbol":"NBP"},"owners":[{"id":36207,"kind":"person","name":"Dennis Phillip Andrew","position":1,"cik":"0002089237","reported_name":"Dennis Phillip Andrew","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Ordinary Shares","published_at":"2026-09-21T20:05:06.000Z","date":"2026-09-18","kind":"sale","planned":false,"acquired":false,"shares":8209,"price":0.71,"value":5828.39,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares (\"ADS\"). Each 10 ADSs represent 23 Ordinary Shares of the Issuer."},{"field":"shares","element":"transactionShares","label":"F5","text":"Reported securities are represented by 3,569 ADSs."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"Reported sales price represents the converted sales price of the ADSs of $1.6247."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F7","text":"Reported securities are represented by 75,403 ADSs."}],"balance_after":173427,"source":{"system":"sec-edgar","filing":"0002089237-26-000008","document":"form4-09212026_040901.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2089237/000208923726000008/form4-09212026_040901.xml","form_type":"4"}},{"id":4623138,"issuer":{"id":6324,"kind":"organization","name":"NovaBridge Biosciences","symbol":"NBP"},"owners":[{"id":36207,"kind":"person","name":"Dennis Phillip Andrew","position":1,"cik":"0002089237","reported_name":"Dennis Phillip Andrew","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Ordinary Shares","published_at":"2026-09-21T20:05:06.000Z","date":"2026-09-17","kind":"exercise","planned":false,"acquired":true,"shares":23695,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares (\"ADS\"). Each 10 ADSs represent 23 Ordinary Shares of the Issuer."},{"field":"shares","element":"transactionShares","label":"F2","text":"Reported securities are represented by 10,302 ADSs."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one ADS."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"Reported securities are represented by 78,972 ADSs."}],"balance_after":181636,"source":{"system":"sec-edgar","filing":"0002089237-26-000008","document":"form4-09212026_040901.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2089237/000208923726000008/form4-09212026_040901.xml","form_type":"4"}},{"id":729980,"issuer":{"id":6324,"kind":"organization","name":"NovaBridge Biosciences","symbol":"NBP"},"owners":[{"id":36207,"kind":"person","name":"Dennis Phillip Andrew","position":1,"cik":"0002089237","reported_name":"Dennis Phillip Andrew","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Restricted Share Units","published_at":"2026-06-22T21:23:50.000Z","date":"2026-06-17","kind":"exercise","planned":false,"acquired":false,"shares":10302,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one ADS."},{"field":"shares","element":"transactionShares","label":"F8","text":"Reported securities represent ADSs."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F9","text":"On June 17, 2024, the Reporting Person was granted 164,840 RSUs. The RSUs vested or shall vest over four years, with one-fourth vesting on the first anniversary of the grant date and the balance vesting ratably over the subsequent 12 quarters on the 17th day of each third month."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F9","text":"On June 17, 2024, the Reporting Person was granted 164,840 RSUs. The RSUs vested or shall vest over four years, with one-fourth vesting on the first anniversary of the grant date and the balance vesting ratably over the subsequent 12 quarters on the 17th day of each third month."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares (\"ADS\"). Each 10 ADSs represent 23 Ordinary Shares of the Issuer."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F8","text":"Reported securities represent ADSs."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F8","text":"Reported securities represent ADSs."}],"balance_after":82422,"derivative":{"underlying":"Ordinary Shares","underlying_shares":10302},"source":{"system":"sec-edgar","filing":"0002089237-26-000006","document":"form4-06222026_090646.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1778016/000208923726000006/form4-06222026_090646.xml","form_type":"4"}},{"id":729979,"issuer":{"id":6324,"kind":"organization","name":"NovaBridge Biosciences","symbol":"NBP"},"owners":[{"id":36207,"kind":"person","name":"Dennis Phillip Andrew","position":1,"cik":"0002089237","reported_name":"Dennis Phillip Andrew","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Ordinary Shares","published_at":"2026-06-22T21:23:50.000Z","date":"2026-06-18","kind":"sale","planned":false,"acquired":false,"shares":8494,"price":0.66,"value":5606.04,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares (\"ADS\"). Each 10 ADSs represent 23 Ordinary Shares of the Issuer."},{"field":"shares","element":"transactionShares","label":"F5","text":"Reported securities are represented by 3,693 ADSs."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"Reported sales price represents the converted sales price of the ADSs of $1.51."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F7","text":"Reported securities are represented by 68,670 ADSs."}],"balance_after":157941,"source":{"system":"sec-edgar","filing":"0002089237-26-000006","document":"form4-06222026_090646.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1778016/000208923726000006/form4-06222026_090646.xml","form_type":"4"}},{"id":729978,"issuer":{"id":6324,"kind":"organization","name":"NovaBridge Biosciences","symbol":"NBP"},"owners":[{"id":36207,"kind":"person","name":"Dennis Phillip Andrew","position":1,"cik":"0002089237","reported_name":"Dennis Phillip Andrew","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Ordinary Shares","published_at":"2026-06-22T21:23:50.000Z","date":"2026-06-17","kind":"exercise","planned":false,"acquired":true,"shares":23695,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares (\"ADS\"). Each 10 ADSs represent 23 Ordinary Shares of the Issuer."},{"field":"shares","element":"transactionShares","label":"F2","text":"Reported securities are represented by 10,302 ADSs."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one ADS."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"Reported securities are represented by 72,363 ADSs."}],"balance_after":166435,"source":{"system":"sec-edgar","filing":"0002089237-26-000006","document":"form4-06222026_090646.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1778016/000208923726000006/form4-06222026_090646.xml","form_type":"4"}}]}